Primary Site >> Colorectal Cancer
Gene >> PROK1
| 1. | |||||||||||
| Journal: | Clin Cancer Res. 1999 Jan;5(1):83-94. | ||||||||||
| Title: | Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. | ||||||||||
| Author: | Vasey, P A|Kaye, S B|Morrison, R|Twelves, C|Wilson, P|Duncan, R|Thomson, A H|Murray, L S|Hilditch, T E|Murray, T|Burtles, S|Fraier, D|Frigerio, E|Cassidy, J | ||||||||||
| PMID: | 9918206 | ||||||||||
| 2. | |||||||||||
| Journal: | Eur J Nutr. 1999 Jun;38(3):133-42. | ||||||||||
| Title: | Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. | ||||||||||
| Author: | Kuntz, S|Wenzel, U|Daniel, H | ||||||||||
| PMID: | 10443335 | ||||||||||
| 3. | |||||||||||
| Journal: | Curr Opin Mol Ther. 2003 Jun;5(3):326-30. | ||||||||||
| Title: | Technology evaluation: PK1, Pfizer/Cancer Research UK. | ||||||||||
| Author: | Bilim, Vladimir | ||||||||||
| PMID: | 12870445 | ||||||||||
| 4. | |||||||||||
| Journal: | Cancer Res. 2004 Mar 15;64(6):1906-10. | ||||||||||
| Title: | Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. | ||||||||||
| Author: | Goi, Takanori|Fujioka, Masako|Satoh, Yoshiki|Tabata, Shinsuke|Koneri, Kenji|Nagano, Hideki|Hirono, Yasuo|Katayama, Kanji|Hirose, Kazuo|Yamaguchi, Akio | ||||||||||
| PMID: | 15026321 | ||||||||||
| 5. | |||||||||||
| Journal: | J Surg Oncol. 2007 Dec 1;96(7):605-10. | ||||||||||
| Title: | Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer. | ||||||||||
| Author: | Nagano, Hideki|Goi, Takanori|Koneri, Kenji|Hirono, Yasuo|Katayama, Kanji|Yamaguchi, Akio | ||||||||||
| PMID: | 17786959 | ||||||||||
| 6. | |||||||||||
| Journal: | Int J Oncol. 2009 Jun;34(6):1629-36. | ||||||||||
| Title: | Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. | ||||||||||
| Author: | Seymour, Leonard W|Ferry, David R|Kerr, David J|Rea, Daniel|Whitlock, Maggie|Poyner, Richard|Boivin, Christopher|Hesslewood, Stuart|Twelves, Christopher|Blackie, Robert|Schatzlein, Andreas|Jodrell, Duncan|Bissett, Donald|Calvert, Hilary|Lind, Mike|Robbins | ||||||||||
| PMID: | 19424581 | ||||||||||
| 7. | |||||||||||
| Journal: | Oncol Rep. 2013 Feb;29(2):459-63. | ||||||||||
| Title: | Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines. | ||||||||||
| Author: | Tabata, Shinsuke|Goi, Takanori|Nakazawa, Toshiyuki|Kimura, Youhei|Katayama, Kanji|Yamaguchi, Akio | ||||||||||
| PMID: | 23135359 | ||||||||||
| 8. | |||||||||||
| Journal: | Anticancer Res. 2013 Dec;33(12):5311-5. | ||||||||||
| Title: | Prokineticin 1 expression in gastrointestinal tumors. | ||||||||||
| Author: | Goi, Takanori|Nakazawa, Toshiyuki|Hirono, Yasuo|Yamaguchi, Akio | ||||||||||
| PMID: | 24324064 | ||||||||||
| 9. | |||||||||||
| Journal: | Ann Surg Oncol. 2014 Dec;21 Suppl 4:S665-71. | ||||||||||
| Title: | Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer. | ||||||||||
| Author: | Goi, Takanori|Nakazawa, Toshiyuki|Hirono, Yasuo|Yamaguchi, Akio | ||||||||||
| PMID: | 24838366 | ||||||||||
| 10. | |||||||||||
| Journal: | Ann Surg Oncol. 2015 May;22(5):1496-503. | ||||||||||
| Title: | Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer. | ||||||||||
| Author: | Nakazawa, Toshiyuki|Goi, Takanori|Hirono, Yasuo|Yamaguchi, Akio | ||||||||||
| PMID: | 25331005 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncotarget. 2015 Mar 20;6(8):6053-61. | ||||||||||
| Title: | The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer. | ||||||||||
| Author: | Goi, Takanori|Nakazawa, Toshiyuki|Hirono, Yasuo|Yamaguchi, Akio | ||||||||||
| PMID: | 25788276 | ||||||||||
| 12. | |||||||||||
| Journal: | Oncotarget. 2015 Oct 6;6(30):28790-9. | ||||||||||
| Title: | The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1). | ||||||||||
| Author: | Goi, Takanori|Nakazawa, Toshiyuki|Hirono, Yasuo|Yamaguchi, Akio | ||||||||||
| PMID: | 26318037 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Biomark. 2018 Feb 6;21(2):345-354. | ||||||||||
| Title: | Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis. | ||||||||||
| Author: | Benlahfid, Mohammed|Traboulsi, Wael|Sergent, Frederic|Benharouga, Mohamed|Elhattabi, Khalid|Erguibi, Driss|Karkouri, Mehdi|Elattar, Hicham|Fadil, Abdelaziz|Fahmi, Yassine|Aboussaouira, Touria|Alfaidy, Nadia | ||||||||||
| PMID: | 29226856 | ||||||||||